Peter Lohse

发表

Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view

B. Reichart, S. Eifert, A. Beiras-Fernandez, 2011, Inflammation Research.

Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn’s disease

B. Müller-Myhsok, S. Brand, J. Glas, 2005, Gut.

Multiple sclerosis and the TNFRSF1A R92Q mutation

R. Hohlfeld, W. Feneberg, T. Kümpfel, 2008, Neurology.

Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms?

D. Aust, G. Baretton, R. Kopp, 2001, European journal of medical research.

Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer

D. Aust, M. Muders, G. Keller, 2005, Gut.

The role of fatty acid hydrolase gene variants in inflammatory bowel disease

S. Brand, B. Göke, M. Storr, 2009, Alimentary pharmacology & therapeutics.

Concurrent TNFRSF1A R92Q and pyrin E230K mutations in a child with multiple sclerosis

F. Heinen, R. Hohlfeld, I. Borggraefe, 2010, Multiple sclerosis.

Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer.

A. Chlumská, S. Maas, M. Elleder, 2000, Journal of hepatology.

Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk

A. Ho, U. Hegenbart, S. Schönland, 2013, Scandinavian journal of rheumatology.